Marino Garcia's most recent trade in Dianthus Therapeutics Inc was a trade of 340,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | |
Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 243,000 | 243,000 | - | - | Stock Option (Right to Buy) | |
Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) |